Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

Author： Gilfrich Hans Joachim   Schott Gisela  

Publisher： Govi-Verlag

ISSN： 2195-2175

Source： PHARMAKON, Vol.1, Iss.4, 2013-07, pp. : 313-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3816-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

By  

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite

Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients

By Di Minno Matteo Nicola Dario  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 9-23

Informa Healthcare

Access to resources Recommend Favorite

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 2055-2069

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation prescription in atrial fibrillation

By Bertomeu-Gonzáález Vicente   Cordero Alberto   Mazóón Pilar   Moreno-Arribas Joséé   Fáácila Lorenzo   Nuññez Julio   Rodrííguez-Maññero Moiséés   Cosíín-Sales Juan   Gonzáález-Juanatey Jose Ramóón   Quiles Juan   Bertomeu-Martíínez Vicente  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1473-1479

Informa Healthcare

Access to resources Recommend Favorite